ETF Trends
05-10-2008, 05:32 AM
ETF Trends - Keeping a Grip on Exchange Traded Funds (ETFs)
[/URL]
[URL="http://etftrends.typepad.com/photos/uncategorized/2008/05/09/4264618075.jpeg"] (http://etftrends.typepad.com/photos/uncategorized/2008/05/09/4271132991.jpeg)
http://www.etftrends.com/images/2008/05/09/biotech.jpg Biotechnology is rising up to analyst's predictions that a near future run could send related stocks and exchange traded funds (ETFs) up. The latest April announcement that Takeda Pharmaceutical would buy Massachusetts-based Millennium Pharmaceuticals ([B]reports Don Dion for Seeking Alpha (http://finance.yahoo.com/q?s=mlmn).
Millennium sells the anti-cancer injection drug Velcade, and is lifting investor's expectations for a biotech sector run. PowerShares Dynamic Biotech & Genome (XBI (http://finance.yahoo.com/q?s=pbe&x=0&y=0)), down 3.9% year-to-dateiShares NASDAQ Biotechnology (FBT (http://finance.yahoo.com/q/hl?s=IBB)), down 4.9% year-to-date
Biotech HOLDRs (<a href="http://finance.yahoo.com/q?s=bbh" target="_blank"">BBH),holds 1% in MLMN, up 1.8% year-to-date
</ul><a href="http://etftrends.typepad.com/photos/uncategorized/2008/05/09/z_7.png">http://www.etftrends.com/images/2008/05/09/z_7.png
complete story here... (http://feeds.feedburner.com/~r/etftrends-feed/~3/287369187/biotechgenome-e.html)
[/URL]
[URL="http://etftrends.typepad.com/photos/uncategorized/2008/05/09/4264618075.jpeg"] (http://etftrends.typepad.com/photos/uncategorized/2008/05/09/4271132991.jpeg)
http://www.etftrends.com/images/2008/05/09/biotech.jpg Biotechnology is rising up to analyst's predictions that a near future run could send related stocks and exchange traded funds (ETFs) up. The latest April announcement that Takeda Pharmaceutical would buy Massachusetts-based Millennium Pharmaceuticals ([B]reports Don Dion for Seeking Alpha (http://finance.yahoo.com/q?s=mlmn).
Millennium sells the anti-cancer injection drug Velcade, and is lifting investor's expectations for a biotech sector run. PowerShares Dynamic Biotech & Genome (XBI (http://finance.yahoo.com/q?s=pbe&x=0&y=0)), down 3.9% year-to-dateiShares NASDAQ Biotechnology (FBT (http://finance.yahoo.com/q/hl?s=IBB)), down 4.9% year-to-date
Biotech HOLDRs (<a href="http://finance.yahoo.com/q?s=bbh" target="_blank"">BBH),holds 1% in MLMN, up 1.8% year-to-date
</ul><a href="http://etftrends.typepad.com/photos/uncategorized/2008/05/09/z_7.png">http://www.etftrends.com/images/2008/05/09/z_7.png
complete story here... (http://feeds.feedburner.com/~r/etftrends-feed/~3/287369187/biotechgenome-e.html)